Identification and characterization of novel angiotensin-converting enzyme inhibitors obtained from goat milk

Journal of Dairy Science

Volumn 89, Issue 9, 2006, Pages 3326-3335

  Geerlings, A ^a   Villar, I C ^b   Zarco, F Hidalgo ^a   Sanchez M ^b   Vera, R ^b   Gomez, A Zafra ^a   Boza, J ^a   Duarte, J ^b  

^a Puleva Biotech SA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Angiotensin converting enzyme inhibitor; Bioactive peptide; Goat milk; Spontaneously hypertensive rat

Indexed keywords

ANIMALIA; CAPRA HIRCUS;

EID: 33748124256     PISSN: 00220302     EISSN: None     Source Type: Journal    
DOI: 10.3168/jds.S0022-0302(06)72369-4     Document Type: Article

References (38)

1. Abubakar, A., T. Saito, H. Kitazawa, Y. Kawai, and T. Itoh. 1998. Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion. J. Dairy Sci. 81:3131-3138.
2. Aihara, K., O. Kajimoto, H. Hirata, R. Takahashi, and Y. Nakamura. 2005. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J. Am. Coll. Nutr. 24:257-265.
3. Ariyoshi, Y. 1993. Angiotensin-converting enzyme inhibitors derived from food proteins. Trends Food Sci. Technol. 4:139-144.
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
5. Brown, N. J., and D. E. Vaughan. 1998. Angiotensin-converting enzyme inhibitors. Circulation 97:1411-1420.
6. Campbell, D. J., A. M. Duncan, A. Kladis, and S. B. Harrap. 1995. Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats. Hypertension 25:928-934.
7. Chen, S., J. Su, K. Wu, W. Hu, D. G. Gardner, and D. Chen. 1998. Early captopril treatment prevents hypertrophy-dependent gene expression in hearts of SHR. Am. J. Physiol. 274:R1511-R1517.
8. Duarte, J., R. Perez-Palencia, F. Vargas, M. A. Ocete, F. Perez-Vizcaino, A. Zarzuelo, and J. Tamargo. 2001. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br. J. Pharmacol. 133:117-124.
9. Dworkin, L. D., M. Grosser, H. D. Feiner, M. Ullian, and M. Parker. 1989. Renal vascular effects of antihypertensive therapy in uninephrectomized SHR. Kidney Int. 35:790-798.
10. FitzGerald, R. J., B. A. Murray, and D. J. Walsh. 2004. Hypotensive peptides from milk proteins. J. Nutr. 134:9808-9888.
11. Frohlich, E. D., C. Apstein, A. V. Chobanian, R. B. Devereux, H. P. Dustan, V. Dzau, F. Fauad-Tarazi, M. J. Horan, M. Marcus, and B. Massie. 1992. The heart in hypertension. N. Engl. J. Med. 327:998-1008.
12. Fujita, H., and M. Yoshikawa. 1999. LKPNM: A prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology 44:123-127.
13. Hata, Y., M. Yamamoto, M. Ohni, K. Nakajima, Y. Nakamura, and T. Takano. 1996. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am. J. Clin. Nutr. 64:767-771.
14. Lee, R. M., K. H. Berecek, J. Tsoporis, R. McKenzie, and C. R. Triggle. 1991. Prevention of hypertension and vascular changes by captopril treatment. Hypertension 17:141-150.
15. Lynch, J. M., D. M. Barbano, and J. R. Fleming. 1998. Indirect and direct determination of the casein content of milk by Kjeldahl nitrogen analysis: Collaborative study. J. AOAC Int. 81:763-774.
16. Maeno, M., N. Yamamoto, and T. Takano. 1996. Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 79:1316-1321.
17. Meisel, H. 2005. Biochemical properties of peptides encrypted in bovine milk proteins. Curr. Med. Chem. 12:1905-1919.
18. Miguel, M., B. Muguerza, E. Sanchez, M. A. Delgado, I. Recio, M. Ramos, and M. A. Aleixandre. 2005. Changes in arterial blood pressure in hypertensive rats caused by long-term intake of milk fermented by Enterococcus faecalis CECT 5728. Br. J. Nutr. 94:36-43.
19. Mizuno, S., K. Matsuura, T. Gotou, S. Nishimura, O. Kajimoto, M. Yabune, Y. Kajimoto, and N. Yamamoto. 2005. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br. J. Nutr. 94:84-91.
20. Mullally, M. M., H. Meisel, and R. J. FitzGerald. 1996. Synthetic peptides corresponding to alpha-lactalbumin and beta-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol. Chem. Hoppe Seyler 377:259-260.
21. Mullally, M. M., H. Meisel, and R. J. FitzGerald. 1997. Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine beta-lactoglobulin. FEBS Lett. 402:99-101.
22. Murakami, M., H. Tonouchi, R. Takahashi, H. Kitazawa, Y. Kawai, H. Negishi, and T. Saito. 2004. Structural analysis of a new antihypertensive peptide (beta-lactosin B) isolated from a commercial whey product. J. Dairy Sci. 87:1967-1974.
23. Nakamura, Y., N. Yamamoto, K. Sakai, A. Okubo, S. Yamazaki, and T. Takano. 1995a. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J. Dairy Sci. 78:777-783.
24. Nakamura, Y., N. Yamamoto, K. Sakai, and T. Takano. 1995b. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J. Dairy Sci. 78:1253-1257.
25. National Research Council. 1995. Nutrient Requirements of Laboratory Animals. 4th rev. ed. Natl. Acad. Press, Washington, DC.
26. Onaka, U., K. Fujii, I. Abe, and M. Fujishima. 1998. Antihypertensive treatment improves endothelium-dependent hyperpolarization in the mesenteric artery of spontaneously hypertensive rats. Circulation 98:175-182.
27. Parmley, W. W. 1998. Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection. Am. J. Med. 105:27S-31S.
28. Pihlanto-Leppala, A., P. Koskinen, K. Piilola, T. Tupasela, and H. Korhonen. 2000. Angiotensin I-converting enzyme inhibitory properties of whey protein digests: Concentration and characterization of active peptides. J. Dairy Res. 67:53-64.
29. Rodrigo, E., R. Maeso, R. Munoz-Garcia, J. Navarro-Cid, L. M. Ruilope, V. Cachofeiro, and V. Lahera. 1997. Endothelial dysfunction in spontaneously hypertensive rats: Consequences of chronic treatment with losartan or captopril. J. Hypertens. 15:613-618.
30. Schachinger, V., M. B. Britten, and A. M. Zeiher. 2000. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899-1906.
31. Seppo, L., T. Jauhiainen, T. Poussa, and R. Korpela. 2003. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 77:326-330.
32. Sipola, M., P. Finckenberg, R. Korpela, H. Vapaatalo, and M. L. Nurminen. 2002. Effect of long-term intake of milk products on blood pressure in hypertensive rats. J. Dairy Res. 69:103-111.
33. Sipola, M., P. Finckenberg, J. Santisteban, R. Korpela, H. Vapaatalo, and M. L. Nurminen. 2001. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J. Physiol. Pharmacol. 52:745-754.
34. Takai, S., D. Jin, M. Sakaguchi, and M. Miyazaki. 2004. Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors. Hypertens. Res. 27:213-219.
35. Tuomilehto, J., J. Lindstrom, J. Hyyrynen, R. Korpela, M. L. Karhunen, L. Mikkola, T. Jauhiainen, L. Seppo, and A. Nissinen. 2004. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension. J. Hum. Hypertens. 18:795-802.
36. Vanhoutte, P. M. 1996. Endothelial dysfunction in hypertension. J. Hypertens. 14:883-893.
37. Wu, J., R. E. Aluko, and A. D. Muir. 2002. Improved method for direct high-performance liquid chromatography assay of angiotensin-converting enzyme-catalyzed reactions. J. Chromatogr. 950:125-130.
38. Yang, D., M. Feletou, N. Levens, J. N. Zhang, and P. M. Vanhoutte. 2003. A diffusible substance(s) mediates endothelium-dependent contractions in the aorta of SHR. Hypertension 41:143-148.